GATA3/GATA2 Antibody

What are GATA2 and GATA3 transcription factors and why are they important research targets?

GATA2 and GATA3 are members of the GATA family of zinc-finger transcription factors that bind to the consensus nucleotide sequence 5'-AGATAG-3' in the promoter regions of target genes. GATA2 plays an essential role in regulating transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages. GATA3 is indispensable for Ang-1-Tie2-mediated signaling in large vessel endothelial cells and has significant functions in endothelial cell biology . Both factors are expressed in cultured primary human endothelial cells, with GATA3 typically expressed at higher levels compared to GATA2 and GATA6 in human umbilical vein endothelial cells (HUVECs) . Understanding these proteins is critical for research in vascular biology, hematopoiesis, and related pathologies.

What types of GATA2/GATA3 antibodies are available for research applications?

Researchers can utilize several types of GATA2/GATA3 antibodies:

• Dual-specificity antibodies that recognize both GATA2 and GATA3

• Specific antibodies targeting only GATA2

• Specific antibodies targeting only GATA3

These antibodies are available in various forms including:

Both polyclonal antibodies recognizing GATA2+GATA3 (e.g., ARG41622) and recombinant monoclonal antibodies (e.g., EPR24359-3) are commercially available with validated reactivity across human, mouse, and rat samples .

How do I determine whether to use a dual GATA2/GATA3 antibody versus specific antibodies?

The choice between dual-specificity and single-target antibodies depends on your research question:

• Use dual GATA2/GATA3 antibodies when: You want to study both transcription factors simultaneously, you're screening for general GATA family expression, or you're working with limited sample material.

• Use specific antibodies when: You need to distinguish between GATA2 and GATA3 expression, you're studying differential regulation, or you're investigating specific knockout/knockdown models.

For validation experiments, it's recommended to run parallel tests with specific antibodies. For example, K-562 cells express high levels of GATA2 but no expression of GATA3, making them an excellent control for validating specificity . When expression patterns of these factors need to be distinguished, parallel experiments with specific antibodies at optimized dilutions (typically 1:1000, corresponding to 0.3-0.6 μg/ml) are recommended .

What are the optimal conditions for using GATA2/GATA3 antibodies in Western blot applications?

For optimal Western blot results with GATA2/GATA3 antibodies:

When designing Western blot experiments, include appropriate controls. K-562 cells express high levels of GATA2 but no GATA3, making them an excellent control for testing antibody specificity . For GATA3 detection, HUVECs are recommended as they express higher levels of GATA3 compared to GATA2 . Always prepare samples by washing cells with ice-cold PBS, collecting with a cell scraper, and lysing with RIPA buffer for optimal protein extraction .

How should I design immunohistochemistry experiments with GATA2/GATA3 antibodies?

For IHC-P applications with GATA2/GATA3 antibodies:

• Sample preparation: Use formalin-fixed paraffin-embedded sections.

• Antigen retrieval: This step is critical as fixation can mask epitopes. Heat-induced epitope retrieval in citrate buffer (pH 6.0) is typically effective.

• Antibody concentration: Start with manufacturer's recommended dilution (often 1:100 to 1:500) and optimize as needed.

• Controls:

  • Positive control: Include tissue known to express GATA2/GATA3 (endothelial cells for both)

  • Negative control: Include sections incubated with isotype-matched IgG

• Interpretation: GATA3 is primarily localized in the nucleus in endothelial cells, as confirmed by immunohistochemical analyses . Expect nuclear staining pattern for both GATA2 and GATA3.

• Dual staining considerations: When investigating co-expression with other markers, consider fluorescent secondary antibodies for co-localization studies.

What cell types and tissues are appropriate positive controls for GATA2/GATA3 antibody validation?

When validating antibodies, consider that expression levels vary by cell type. HUVECs demonstrate higher levels of GATA3 protein (approximately 10-fold) compared to GATA2 or GATA6, while human dermal microvascular endothelial cells show lower levels of GATA3 mRNA . This differential expression pattern can be utilized to confirm antibody specificity.

How can I optimize immunoprecipitation protocols using GATA2/GATA3 antibodies?

For successful immunoprecipitation (IP) with GATA2/GATA3 antibodies:

• Sample preparation:

  • For cell lysates: Use a gentle lysis buffer containing non-ionic detergents (e.g., NP-40)

  • For chromatin immunoprecipitation (ChIP): Crosslink with formaldehyde (typically 1%) for 10 minutes

• Antibody amount:

  • Start with 10 μg of anti-GATA3 or control IgG for ChIP applications

  • For protein IP, 2-5 μg of antibody per 500 μg of protein lysate is typically effective

• IP procedure:

  • Pre-clear lysates with protein A/G beads

  • Incubate with antibody overnight at 4°C

  • Add fresh protein A/G beads and incubate 1-2 hours

  • Wash extensively (minimum 3-5 washes)

• Controls:

  • Include isotype-matched IgG control

  • Consider including a known target as positive control

• Analysis:

  • For ChIP, quantitative real-time PCR can be performed with specific primer pairs

  • For protein IP followed by Western blot, probe for expected interaction partners

When performing ChIP to investigate GATA3 binding to regulatory regions, washing and eluting chromatin complexes according to standard protocols (e.g., Upstate Biotechnology) is recommended .

What are the critical factors for successful flow cytometry with GATA2/GATA3 antibodies?

For optimal flow cytometry results:

• Fixation and permeabilization:

  • Use paraformaldehyde (2-4%) for fixation

  • Select appropriate permeabilization reagent (e.g., 0.1% Triton X-100 or commercial intracellular staining kits)

  • GATA2/GATA3 are nuclear transcription factors requiring robust permeabilization

• Antibody titration:

  • Determine optimal concentration using serial dilutions (typically starting at 1:100)

  • Assess signal-to-noise ratio

• Controls:

  • Fluorescence minus one (FMO) controls

  • Isotype controls matched to primary antibody

  • Positive controls (K-562 for GATA2, HUVECs for GATA3)

  • Negative controls (cell types known not to express target)

• Analysis considerations:

  • Gate on viable single cells

  • Compare median fluorescence intensity (MFI) between samples

  • Consider co-staining with cell type-specific markers

Flow cytometry with GATA2/GATA3 antibodies is specifically suitable for intracellular staining applications, as indicated by validated antibodies like EPR24359-3 .

How do I troubleshoot high background or non-specific binding with GATA2/GATA3 antibodies?

When encountering high background or non-specific binding:

• Antibody dilution optimization:

  • Test serial dilutions to find optimal concentration

  • For Western blot, start with recommended 1:1000 dilution (0.4 μg/ml)

• Blocking optimization:

  • Increase blocking time (1-2 hours at room temperature)

  • Test different blocking agents (BSA, milk, commercial blockers)

  • For Western blots, TBS-T containing 2% skim milk is recommended

• Washing stringency:

  • Increase number of washes

  • Consider adding low concentrations of detergent to wash buffers

  • Ensure adequate washing time between steps

• Sample preparation:

  • For Western blot: Ensure proper cell lysis and protein denaturation

  • For IHC: Optimize antigen retrieval conditions

• Antibody specificity verification:

  • Run parallel experiments with specific antibodies

  • Include knockout/knockdown controls when possible

  • Use K-562 cells as a control that expresses GATA2 but not GATA3

How can GATA2/GATA3 antibodies be used to investigate transcriptional regulation mechanisms?

GATA2/GATA3 antibodies are valuable tools for studying transcriptional regulation through several advanced approaches:

• Chromatin Immunoprecipitation (ChIP):

  • Use anti-GATA3 antibodies (10 μg) to immunoprecipitate DNA-protein complexes

  • Identify binding sites within regulatory regions, such as the 5'-untranslated region of the Tie2 gene

  • Quantify binding using real-time PCR with specific primer pairs

• Protein-Protein Interaction Studies:

  • Co-immunoprecipitation to identify transcription factor complexes

  • GATA3 physically interacts with the Ets transcription factor ELF1, as demonstrated through co-IP and co-transfection assays

  • These factors synergize to transactivate the Tie2 promoter

• Functional Knockdown Studies:

  • Use GATA3 knockdown combined with antibody detection to study functional outcomes

  • Example: GATA3 knockdown blocks the ability of Ang-1 to attenuate vascular endothelial cell growth factor stimulation of vascular cell adhesion molecule-1 expression and monocytic cell adhesion

• Promoter Analysis:

  • Combine ChIP data with reporter assays to validate functional importance of binding sites

  • GATA3 binds to the consensus sequence 5'-AGATAG-3' in regulatory regions

What insights can be gained from studying GATA2/GATA3 expression in pathological conditions?

Investigating GATA2/GATA3 expression in disease states using antibody-based approaches can reveal:

• Inflammatory Responses:

  • Exposure of HUVECs to tumor necrosis factor-α results in marked down-regulation of GATA3 expression and reduction in Tie2 expression

  • This suggests GATA3 regulation may be a mechanism through which inflammatory mediators disrupt vascular homeostasis

• Vascular Dysfunction:

  • GATA3 is indispensable for Ang-1-Tie2-mediated signaling in large vessel endothelial cells

  • Loss of GATA3 expression may contribute to endothelial dysfunction in vascular pathologies

• Cell Type-Specific Regulation:

  • GATA3 expression differs between large vessel endothelial cells and microvascular endothelial cells

  • This differential expression may contribute to vessel bed-specific pathologies

• Hematopoietic Disorders:

  • Given GATA2's role in hematopoietic lineages, antibody detection can help characterize expression changes in leukemias and other blood disorders

  • K-562 cells (derived from chronic myelogenous leukemia) express high levels of GATA2 but no GATA3

How can GATA2/GATA3 antibodies be used in multi-parameter analysis of signaling networks?

For comprehensive signaling network analysis:

• Multi-color flow cytometry:

  • Combine GATA2/GATA3 staining with other signaling molecules

  • Enables single-cell analysis of transcription factor expression in heterogeneous populations

• Multiplexed immunofluorescence:

  • Sequential staining protocols allow detection of multiple targets

  • Can reveal spatial relationships between GATA factors and other proteins

• Phospho-protein analysis:

  • Combine with phospho-specific antibodies to correlate transcription factor expression with activation states of upstream signaling pathways

  • Useful for understanding regulation of GATA2/GATA3 activity

• Mass cytometry (CyTOF):

  • Antibodies conjugated to rare earth metals

  • Allows simultaneous detection of >40 parameters

  • Can reveal complex relationships between GATA factors and numerous signaling molecules

• Single-cell RNA-seq with protein detection:

  • Combining transcriptome analysis with antibody-based protein detection

  • Correlates GATA2/GATA3 protein levels with transcriptional outputs

What are the optimal storage conditions for GATA2/GATA3 antibodies?

For maximum antibody stability and performance:

Before opening, spin the vial to ensure collection of solution at the bottom. The antibody solution should be gently mixed before use . Most commercially available GATA2/GATA3 antibodies are supplied in buffers containing preservatives like sodium azide (0.02%) and stabilizers like glycerol (50%) .

What quality control measures should be implemented when working with GATA2/GATA3 antibodies?

Implement these quality control practices:

• Batch testing:

  • Test each new lot against previous lots using standard samples

  • Verify correct molecular weight (~50 kDa) in Western blot applications

• Positive controls:

  • Include K-562 cells as positive control for GATA2

  • Use HUVECs as positive control for GATA3

• Negative controls:

  • Include isotype-matched control antibodies

  • Consider cell lines known not to express targets

• Cross-reactivity assessment:

  • When using dual-specificity antibodies, compare results with specific antibodies

  • Run parallel tests with specific antibodies at equivalent concentrations

• Documentation:

  • Record lot numbers, dilutions, and experimental conditions

  • Document antibody performance across different applications